cfDNA

Powering Liquid Biopsies with High-Quality Nucleic Acid

By

Early and accurate cancer monitoring remains a major clinical challenge, particularly when tumor burden is low or after surgical treatment. In the study Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring, researchers demonstrate how advances in whole-genome sequencing (WGS), paired with optimized cell-free DNA (cfDNA) extraction, can dramatically improve the detection of residual or […]

Powering Liquid Biopsies with High-Quality Nucleic Acid Read More »

Advancing Methylation Analysis with Reliable DNA Extraction

By

A recent study in Clinical Epigenetics (Nuttall et al., 2025) explored two ways of studying DNA methylation — an important marker that helps researchers understand how genes are turned on or off. The team compared a newer approach, enzymatic methylation sequencing (EM-seq), with the traditional bisulfite sequencing method, using a variety of real-world samples from

Advancing Methylation Analysis with Reliable DNA Extraction Read More »

Plasma cfDNA Methylation Profiling for Lung Cancer Detection Using Targeted EM-seq

By

Early detection remains one of the greatest challenges in lung cancer, where outcomes are closely tied to how soon disease can be identified. A 2024 study published in Scientific Reports demonstrates how advances in cell-free DNA (cfDNA) analysis—combined with robust nucleic acid extraction—can significantly improve non-invasive cancer detection from blood plasma samples. In this work,

Plasma cfDNA Methylation Profiling for Lung Cancer Detection Using Targeted EM-seq Read More »

Ultra-Sensitive Cancer Monitoring from Plasma cfDNA Using Genome-Wide Sequencing

By

Early and accurate cancer monitoring remains a major clinical challenge, particularly when tumor burden is low or after surgical treatment. In the study Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring, researchers demonstrate how advances in whole-genome sequencing (WGS), paired with optimized cell-free DNA (cfDNA) extraction, can dramatically improve the detection of residual or

Ultra-Sensitive Cancer Monitoring from Plasma cfDNA Using Genome-Wide Sequencing Read More »

Shopping Cart
Scroll to Top